Title
|
PubMed Id
|
Authors
|
Journal Abbreviation
|
Year
|
Studies
|
Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants. |
28050695
|
Gierada DS, Pinsky PF, Duan F, Garg K, Hart EM, Kazerooni EA, Nath H, Watts JR, Aberle DR |
Eur Radiol |
2017 |
NLST |
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. |
28376113
|
Ten Haaf K, Jeon J, Tammemägi MC, Han SS, Kong CY, Plevritis SK, Feuer EJ, de Koning HJ, Steyerberg EW, Meza R |
PLoS Med. |
2017 |
NLST, PLCO |
Malignancy estimation of Lung-RADS criteria for subsolid nodules on CT: accuracy of low and high risk spectrum when using NLST nodules. |
28439653
|
Chung K, Jacobs C, Scholten ET, Mets OM, Dekker I, Prokop M, van Ginneken B, Schaefer-Prokop CM |
Eur Radiol |
2017 |
NLST |
Lung-RADS Category 4X: Does It Improve Prediction of Malignancy in Subsolid Nodules? |
28339311
|
Chung K, Jacobs C, Scholten ET, Goo JM, Prosch H, Sverzellati N, Ciompi F, Mets OM, Gerke PK, Prokop M, van Ginneken B, Schaefer-Prokop CM |
Radiology |
2017 |
NLST |
Computed tomographic findings in subjects who died from respiratory disease in the National Lung Screening Trial. |
28424361
|
Pompe E, de Jong PA, Lynch DA, Lessmann N, Išgum I, van Ginneken B, Lammers JJ, Mohamed Hoesein FAA |
Eur. Respir. J. |
2017 |
NLST |
WSISA: Making Survival Prediction from Whole Slide Histopathological Images |
|
Xinliang Zhu
Univerisity of Texas at Arlington, Tencent AI Lab
Jiawen Yao
Univerisity of Texas at Arlington, Tencent AI Lab
Feiyun Zhu
Univerisity of Texas at Arlington, Tencent AI Lab
Junzhou Huang
Univerisity of Texas at Arlington, Tencent … |
IEEE |
2017 |
NLST |
Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial. |
28245151
|
Yip R, Henschke CI, Xu DM, Li K, Jirapatnakul A, Yankelevitz DF |
AJR Am J Roentgenol |
2017 |
NLST |
Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada. |
28170394
|
Ten Haaf K, Tammemägi MC, Bondy SJ, van der Aalst CM, Gu S, McGregor SE, Nicholas G, de Koning HJ, Paszat LF |
PLoS Med |
2017 |
NLST |
ConvNet-Based Localization of Anatomical Structures in 3-D Medical Images. |
28252392
|
de Vos BD, Wolterink JM, de Jong PA, Leiner T, Viergever MA, Isgum I |
IEEE Trans Med Imaging |
2017 |
NLST |
Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. |
27009070
|
Patz EF, Greco E, Gatsonis C, Pinsky P, Kramer BS, Aberle DR |
Lancet Oncol. |
2016 |
NLST |
Did death certificates and a death review process agree on lung cancer cause of death in the National Lung Screening Trial? |
27006427
|
Marcus PM, Doria-Rose VP, Gareen IF, Brewer B, Clingan K, Keating K, Rosenbaum J, Rozjabek HM, Rathmell J, Sicks J, Miller AB |
Clin Trials |
2016 |
NLST |
CANARY Risk Management of Adenocarcinoma: The Future of Imaging? |
|
Finbar Foley
Srinivasan Rajagopalan
Sushravya M. Raghunath
Jennifer M. Boland
Ronald A. Karwoski
Fabien Maldonado
Brian J. Bartholmai
Tobias Peikert
|
j.semtcsv |
2016 |
NLST |
Normative reference values of thoracic aortic diameter in American College of Radiology Imaging Network (ACRIN 6654) arm of National Lung Screening Trial |
27203287
|
Barbara L. McComb, Reginald F. Munden, Fenghai Duan, Amanda A. Jain, Catherine Tuite, Caroline Chiles |
Clin Imaging |
2016 |
NLST |
Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening. |
27179989
|
Katki HA, Kovalchik SA, Berg CD, Cheung LC, Chaturvedi AK |
JAMA |
2016 |
NLST |
The Potential Clinical, Resource Use, And Fiscal Impacts of Lung-Rads To Inform Lung Cancer Screening In Medicare |
|
J. Roth, S.D. Sullivan, S. Ramsey, B. Goulart |
Val Health |
2016 |
NLST |
Lung Cancer Deaths in the National Lung Screening Trial Attributed to Nonsolid Nodules. |
27378239
|
Yip R, Yankelevitz DF, Hu M, Li K, Xu DM, Jirapatnakul A, Henschke CI |
Radiology |
2016 |
NLST |
Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. |
27387658
|
Balekian AA, Tanner NT, Fisher JM, Silvestri GA, Gould MK |
Ann Am Thorac Soc |
2016 |
NLST |
Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration. |
27330355
|
Evans WK, Flanagan WM, Miller AB, Goffin JR, Memon S, Fitzgerald N, Wolfson MC |
Curr Oncol |
2016 |
NLST |
Prediction of lung cancer incidence on the low-dose computed tomography arm of the National Lung Screening Trial: A dynamic Bayesian network. |
27664507
|
Petousis P, Han SX, Aberle D, Bui AA |
Artif Intell Med |
2016 |
NLST |
Estimation of the tumor size at cure threshold among aggressive non-small cell lung cancers (NSCLCs): Evidence from The Surveillance, Epidemiology, and End Results Program (SEER) and the National Lung Screening Trial (NLST). |
27925181
|
Goldwasser DL |
Int. J. Cancer |
2016 |
NLST |